Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05308017 · ClinicalTrials.gov registry record · NA
Wolf 24 F vs. Storz 28 F Laser Sheath Size for HoLEP
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT05308017: Completed NA study, sponsored by Northwestern University.
NCT05308017 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 152 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05308017, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two different types of scopes that can be used for HoLEP. HoLEP is performed through the urethra using a Laser scope to remove obstructing prostate tissue. Laser scopes come in different sizes (diameters).
Primary Outcome
comparing operative time between the 24F and the 28F laser scope groups.
Interventions
- DEVICE Richard Wolf 24F Laser scope
- DEVICE Karl Storz 28F Laser Scope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2023-09-29 |
| Phase | NA |
What the finished NCT05308017 record still lists
NCT05308017 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Richard Wolf 24F Laser scope is the first listed.
NCT05308017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05308017 about?
NCT05308017 is a clinical study titled "Wolf 24 F vs. Storz 28 F Laser Sheath Size for HoLEP". The purpose of this study is to compare two different types of scopes that can be used for HoLEP. HoLEP is performed through the urethra using a Laser scope to remove obstructing prostate tissue. Laser scopes come in different sizes (diameters).
What is the current status of trial NCT05308017?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2022-05-01. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT05308017?
The interventions under investigation include: Richard Wolf 24F Laser scope (DEVICE), Karl Storz 28F Laser Scope (DEVICE).
Who is sponsoring clinical trial NCT05308017?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05308017's enrollment target sits among peer trials
152 658th of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI